Fibrinolytic activated protein from cantharis, preparation method and application thereof
A technology of active protein and fibrinolysis, applied in the application of medicine, in the field of extraction of fibrinolytic active protein in Cantharidin, can solve the problems of low antigen response, short half-life, high price, etc. live high effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0032] The present invention can be described in detail below by way of examples, but these examples do not limit the scope of the present invention in any way. Embodiment 1: Preparation of mylabris fibrinolytic activity protein
[0033] Material: Mylabris (origin: China)
[0034] preparation:
[0035] 1. Preparation of crude extract
[0036] Weigh 10g of cantharidin, cut it into pieces, add 100mL of pre-cooled 0.02mol / L sodium phosphate buffer solution (pH7.4) at a ratio of 1:10 (dry weight: volume), soak for 2h, grind until it becomes minced, and store at 4°C Leach overnight. Centrifuge the extract in a high-speed centrifuge at 8,000 rpm at 4°C for 15 minutes, collect the supernatant, add solid ammonium sulfate to the supernatant to reach 20% saturation, and centrifuge at 8,000 rpm at 4°C Centrifuge in the machine for 30min, collect the supernatant; then add solid ammonium sulfate to reach 80% saturation, centrifuge in a high-speed centrifuge at 4°C for 30min at 8000 rpm...
Embodiment 2
[0041] Embodiment 2: Determination of biological activity of mylabris fibrinolytic activity protein of the present invention
[0042] The assay method of fibrinolytic activity is well known to those skilled in the art. Because the fibrinolytic plate method is highly sensitive and can be both qualitative and quantitative, the fibrinolytic plate method was used in this study. The specific methods are as follows:
[0043]Reagent: bovine fibrinogen solution, concentration 10mg / mL, bovine fibrinogen is a product of Sigma; bovine thrombin, concentration 100U / mL, bovine thrombin is a product of Sigma; urokinase, urokinase is a product of Sigma .
[0044] operate:
[0045] To prepare a fibrin plate, dissolve 0.1g of agarose in 12mL of phosphate buffer (PBS, pH=7.6), boil, cool and keep warm in a water bath at 50°C, add 0.5mL of fibrinogen solution (10mg / ml) and 20μL of thrombin (100u / ml) solution, after mixing, quickly pour it into a 50°C preheated petri dish (diameter 9cm), let it...
Embodiment 3
[0046] Embodiment 3: In vitro thrombolysis experiment and hemolysis experiment containing fibrinolytic active protein of the present invention
[0047] The in vitro thrombolytic experiment uses mouse thrombus as a model to determine the in vitro thrombolytic effect of the fibrinolytic active protein of the present invention; and the hemolytic experiment is an important indicator for investigating the safety of injections, and the mouse blood is used as a model to determine the fibrinolytic activity of the present invention. Whether the administration of protein as an injection for the treatment of thrombus will cause a hemolytic reaction; the above experimental method is well known to those skilled in the art, and is easy to operate and convincing. The specific method is as follows:
[0048] Reagents: mouse blood (blood was taken from the orbit of mice used for experiments); urokinase, urokinase is a product of Sigma Company.
[0049] operate:
[0050] Thrombolytic experiment...
PUM
Property | Measurement | Unit |
---|---|---|
Molecular weight | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com